Kitov Pharmaceuticals Hldgs L Sponsored ADR (KTOV)

[Nojunk]

Hope this has a similar run, though biotechs have been beaten down compared to ADXS's run in early 2015. For those not into warrants yet, ADXSW had a run from 1.5 to 25 corresponding to the rise in stock price. All about exposure, and we're definitely getting some now, much as the exposure ADXS received with the Adage stock purchase, though to a lesser extent. Quite frankly, KTOV's share structure seems to be much better with an actual successful phase 3. This seems too good to be true. Not taking a chance by trading these scarce shares.